FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Adorjan Aszalos

Research Profile

Concepts & Ideas

Membrane Potentials

Chemicals & Drugs

Procedures

Flow Cytometry

Anatomy

Physiology

Living Beings

Mouse

Co-author Network

Publications

TOP 3
Adorjan Aszalos; Barbara J Taylor
Flow cytometric evaluation of multidrug resistance proteins.
Xing-Jie Liang; Jun-Jie Yin; Barbara Taylor; Stephen M Winkovitch; Susan H Garfield; Ding-Wu Shen; Michael M Gottesman; Adorjan Aszalos
Disruption of microfilaments by cytochalasin B decreases accumulation of cisplatin in human epidermal carcinoma and liver carcinoma cell lines.
Xing-Jie Liang; TOREN FINKEL; Ding-Wu Shen; Jun-Jie Yin; Adorjan Aszalos; Michael M Gottesman
SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolism.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Adorjan Aszalos (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Adorjan Aszalos; Barbara J Taylor
Flow cytometric evaluation of multidrug resistance proteins.
Methods in molecular biology (Clifton, N.J.) 2010;596():123-39.
2008: Xing-Jie Liang; Jun-Jie Yin; Barbara Taylor; Stephen M Winkovitch; Susan H Garfield; Ding-Wu Shen; Michael M Gottesman; Adorjan Aszalos
Disruption of microfilaments by cytochalasin B decreases accumulation of cisplatin in human epidermal carcinoma and liver carcinoma cell lines.
Cancer chemotherapy and pharmacology 2008;62(6):977-84.
2008: Xing-Jie Liang; TOREN FINKEL; Ding-Wu Shen; Jun-Jie Yin; Adorjan Aszalos; Michael M Gottesman
SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolism.
Molecular cancer research : MCR 2008;6(9):1499-506.
2007: Adorjan Aszalos
Drug-drug interactions affected by the transporter protein, P-glycoprotein (ABCB1, MDR1) II. Clinical aspects.
Drug discovery today 2007;12(19-20):838-43.
2007: Adorjan Aszalos
Drug-drug interactions affected by the transporter protein, P-glycoprotein (ABCB1, MDR1) I. Preclinical aspects.
Drug discovery today 2007;12(19-20):833-7.
2006: Xing-Jie Liang; Adorjan Aszalos
Multidrug transporters as drug targets.
Current drug targets 2006;7(8):911-21.
2005: Xing-Jie Liang; Barbara Taylor; Carol Cardarelli; Jun-Jie Yin; Jean-Philippe Annereau; Susan H Garfield; Stephen Wincovitch; Gergely Szakács; Michael M Gottesman; Adorjan Aszalos
Different roles for K+ channels in cisplatin-resistant cell lines argue against a critical role for these channels in cisplatin resistance.
Anticancer research 2005;25(6B):4113-22.
2004: Xing-Jie Liang; Jun-Jie Yin; Jien-Wei Zhou; Paul C Wang; Barbara Taylor; Carol Cardarelli; Michael Kozar; Raynard Forte; Adorjan Aszalos; Michael M Gottesman
Changes in biophysical parameters of plasma membranes influence cisplatin resistance of sensitive and resistant epidermal carcinoma cells.
Experimental cell research 2004;293(2):283-91.
2004: Adorjan Aszalos
P-glycoprotein-based drug-drug interactions: preclinical methods and relevance to clinical observations.
Archives of pharmacal research 2004;27(2):127-35.
2003: Claudina Alemán; Jean-Philippe Annereau; Xing-Jie Liang; Carol Cardarelli; Barbara Taylor; Jun-Jie Yin; Adorjan Aszalos; Michael M Gottesman
P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential.
Cancer research 2003;63(12):3084-91.
2003: Adorjan Aszalos
Phenothiazines in treatment of HIV infection (a review).
Acta microbiologica et immunologica Hungarica 2003;50(1):43-53.
2002: Adorjan Aszalos
Specific cell-signal targets for cancer chemotherapy.
Archives of pharmacal research 2002;25(1):1-10.
2001: Adorjan Aszalos; Andrea Ladányi; József Bocsi; Béla Szende
Induction of apoptosis in MDR1 expressing cells by daunorubicin with combinations of suboptimal concentrations of P-glycoprotein modulators.
Cancer letters 2001;167(2):157-62.
1999: Adorjan Aszalos; K Thompson; Jun-Jie Yin; Douglas Ross
Combinations of P-glycoprotein blockers, verapamil, PSC833, and cremophor act differently on the multidrug resistance associated protein (MRP) and on P-glycoprotein (Pgp).
Anticancer research 1999;19(2A):1053-64.
1998: Adorjan Aszalos; Douglas Ross
Biochemical and clinical aspects of efflux pump related resistance to anti-cancer drugs.
Anticancer research 1998;18(4C):2937-44.
1996: James L Weaver; Adorjan Aszalos; L McKinney
MDR1/P-glycoprotein function. II. Effect of hypotonicity and inhibitors on Cl- efflux and volume regulation.
The American journal of physiology 1996;270(5 Pt 1):C1453-60.
1996: James L Weaver; L McKinney; Patricia V Schoenlein; S Goldenberg; Michael M Gottesman; Adorjan Aszalos
MDR1/P-glycoprotein function. I. Effect of hypotonicity and inhibitors on rhodamine 123 exclusion.
The American journal of physiology 1996;270(5 Pt 1):C1447-52.
1996: G Panyi; R Gaspar; Zoltán Krasznai; J J ter Horst; Marcel Ameloot; Adorjan Aszalos; Paul Steels; Sándor Damjanovich
Immunosuppressors inhibit voltage-gated potassium channels in human peripheral blood lymphocytes.
Biochemical and biophysical research communications 1996;221(2):254-8.
1996: M Hwang; C H Ahn; P S Pine; J J Yin; C A Hrycyna; T Licht; Adorjan Aszalos
Effect of combination of suboptimal concentrations of P-glycoprotein blockers on the proliferation of MDR1 gene expressing cells.
International journal of cancer. Journal international du cancer 1996;65(3):389-97.
1995: Adorjan Aszalos; P S Pine; R Pandey; Michael M Gottesman
Behavior of N-acylated daunorubicins in MDR1 gene transfected and parental cells.
Biochemical pharmacology 1995;50(6):889-92.
1995: G Szabó; James L Weaver; P S Pine; P E Rao; Adorjan Aszalos
Cross-linking of CD4 in a TCR/CD3-juxtaposed inhibitory state: a pFRET study.
Biophysical journal 1995;68(3):1170-6.
1994: Adorjan Aszalos; P S Pine; James L Weaver; P E Rao
Cytochalasin D modulates CD4 crosslinking sensitive mitogenic signal in T lymphocytes.
Cellular immunology 1994;157(1):81-91.
1994: G Szabo; P S Pine; James L Weaver; P E Rao; Adorjan Aszalos
The L-selectin (Leu8) molecule is associated with the TcR/CD3 receptor; fluorescence energy transfer measurements on live cells.
Immunology and cell biology 1994;72(4):319-25.
1994: James L Weaver; P S Pine; Adorjan Aszalos
The interaction of immunosuppressive compounds in tandem stimulated peripheral human lymphocytes.
Immunopharmacology and immunotoxicology 1994;16(2):179-90.
1993: G Szabó; James L Weaver; P S Pine; Adorjan Aszalos
Specific disengagement of cell-bound anti-LAM-1 (anti-L-selectin) antibodies by aurintricarboxylic acid.
Molecular immunology 1993;30(18):1689-94.
1993: James L Weaver; G Szabo; P S Pine; Michael M Gottesman; S Goldenberg; Adorjan Aszalos
The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multi-drug transporter.
International journal of cancer. Journal international du cancer 1993;54(3):456-61.
1992: G Szabò; P S Pine; James L Weaver; P E Rao; Adorjan Aszalos
CD4 changes conformation upon ligand binding.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(11):3596-604.
1992: E Balint; Ph M Grimley; R Michalic; Adorjan Aszalos
Modulation of the anti-proliferative signal of interferon-alpha by tamoxifen in U937 cells.
Cancer letters 1992;67(1):13-9.
1992: E Balint; M Cheng; B Rupp; Ph M Grimley; Adorjan Aszalos
Cytoskeletal modulation of plasma membrane events induced by interferon-alpha.
Journal of interferon research 1992;12(4):249-55.
1992: James L Weaver; P S Pine; G Dutschman; Y C Cheng; K H Lee; Adorjan Aszalos
Prevention of binding of rgp120 by anti-HIV active tannins.
Biochemical pharmacology 1992;43(11):2479-80.
1992: G Szabà; P S Pine; James L Weaver; M Kasari; Adorjan Aszalos
Epitope mapping by photobleaching fluorescence resonance energy transfer measurements using a laser scanning microscope system.
Biophysical journal 1992;61(3):661-70.
1991: Adorjan Aszalos; Kailash C Chadha; Istvan Stadler; J L Ambrus; J L Ambrus
Effect of an interferon inhibitor on the antiproliferative signal of interferon-alpha.
Biochemical medicine and metabolic biology 1991;46(2):267-70.
1991: James L Weaver; P S Pine; Adorjan Aszalos; Patricia V Schoenlein; S J Currier; R Padmanabhan; Michael M Gottesman
Laser scanning and confocal microscopy of daunorubicin, doxorubicin, and rhodamine 123 in multidrug-resistant cells.
Experimental cell research 1991;196(2):323-9.
1991: James L Weaver; P S Pine; Adorjan Aszalos
Comparison of the in vitro and biophysical effects of cyclosporine A, FK-506, and mycophenolic acid on human peripheral blood lymphocytes.
Immunopharmacology and immunotoxicology 1991;13(4):563-76.
1991: Adorjan Aszalos; Ph M Grimley; E Balint; Kailash C Chadha; Julian L Ambrus
On the mechanism of action of interferons: interaction with nonsteroidal anti-inflammatory agents, pentoxifylline (Trental) and cGMP inducers.
Journal of medicine 1991;22(4-5):255-71.
1990: Péter Csermely; E Balint; Ph M Grimley; Adorjan Aszalos
Protein kinase C is involved in the early signals of interferon-alpha but not of interferon-gamma in U937 cells.
Journal of interferon research 1990;10(6):605-11.
1990: Y X Gan; James L Weaver; P S Pine; Kathy Zoon; Adorjan Aszalos
Aurin tricarboxylic acid, the anti-AIDS compound, prevents the binding of interferon-alpha to its receptor.
Biochemical and biophysical research communications 1990;172(3):1298-303.
1990: P Gergely; Adorjan Aszalos
Effect of cyclosporin A on the anti-CD3 antibody- and concanavalin A-induced activation and membrane potential of human T lymphocytes.
Immunopharmacology 1990;20(3):191-9.
1990: James L Weaver; P Gergely; P S Pine; E Patzer; Adorjan Aszalos
Polyionic compounds selectively alter availability of CD4 receptors for HIV coat protein rgp120.
AIDS research and human retroviruses 1990;6(9):1125-30.
1989: Adorjan Aszalos; L Tron; J P Siegel; A Johnson
Cyclosporin A modulates K+ fluxes across the plasma membrane of resting lymphocytes without affecting the intracellular pH and [Ca2+].
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):452-3.
1989: L Tron; J P Siegel; Adorjan Aszalos
Effect of cyclosporin A and ionophores on the intracellular pH of lymphocytes as measured by flow cytometry.
Biochemical medicine and metabolic biology 1989;41(2):164-70.
1989: Adorjan Aszalos; L Tron; H Paxton; S Shen
Lymphocyte subpopulation with low membrane potential in the blood of cyclosporin- and prednisone-treated patients: in vivo selectivity for T4 subset.
Biochemical medicine and metabolic biology 1989;41(1):25-9.
1988: E Balint; Adorjan Aszalos; Ph M Grimley
Alpha interferon accelerates lateral diffusion of Daudi cell surface differentiation antigens: measurement by fluorescence redistribution after photobleaching.
Biochemical and biophysical research communications 1988;157(2):808-15.
1988: E Balint; Adorjan Aszalos; P S Pine; Ph M Grimley
Dynamic analyses of lymphoblast membranes exposed to alpha interferon using flow cytometry and fluorescence recovery after photobleaching.
Scanning microscopy 1988;2(4):2153-63.
1988: Adorjan Aszalos
Cyclosporin: some aspects of its mode of action. A review.
Journal of medicine 1988;19(5-6):297-316.
1987: Ph M Grimley; Adorjan Aszalos
Early plasma membrane depolarization by alpha interferon: biologic correlation with antiproliferative signal.
Biochemical and biophysical research communications 1987;146(1):300-6.
1987: Adorjan Aszalos; S Damjanovich; Paul M Colombani; Allan Hess
Lymphocyte populations with different sensitivity to cyclosporin have different plasma membrane potentials.
Journal of medicine 1987;18(5-6):351-74.